Literature DB >> 27024409

Research. Approval of Gilead's Truvada for PrEP passes first hurdle at FDA.

.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 27024409

Source DB:  PubMed          Journal:  AIDS Policy Law        ISSN： 0887-1493


× No keyword cloud information.
  2 in total

1.  Characterization of HIV Seroconverters in a TDF/FTC PrEP Study: HPTN 067/ADAPT.

Authors:  Mariya V Sivay; Maoji Li; Estelle Piwowar-Manning; Yinfeng Zhang; Sarah E Hudelson; Mark A Marzinke; Rivet K Amico; Andrew Redd; Craig W Hendrix; Peter L Anderson; Kevin Bokoch; Linda-Gail Bekker; Frits van Griensven; Sharon Mannheimer; James P Hughes; Robert Grant; Susan H Eshleman
Journal:  J Acquir Immune Defic Syndr       Date:  2017-07-01       Impact factor: 3.731

2.  Healthcare providers' knowledge, readiness, prescribing behaviors, and perceived barriers regarding routine HIV testing and pre-exposure prophylaxis in DeLand, Florida.

Authors:  Laura H Gunn; Brittani Janson; Ismode Lorjuste; Lindsay Summers; Paula Burns; Thomas Bryant
Journal:  SAGE Open Med       Date:  2019-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.